IN8BIO, INC. Files 8-K Report
Ticker: INAB · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure
TL;DR
IN8BIO filed an 8-K on 6/24/25 for 'Other Events'.
AI Summary
On June 24, 2025, IN8bio, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. The company's principal executive offices are located at 350 5th Avenue, Suite 5330, New York, NY 10118.
Why It Matters
This 8-K filing signals that IN8bio, Inc. has reported an event requiring immediate disclosure to the public, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' without immediate disclosed financial or operational impacts.
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- New York, New York (location) — Principal Executive Offices City and State
- 350 5th Avenue, Suite 5330 (location) — Principal Executive Offices Address
- 10118 (location) — Principal Executive Offices Zip Code
FAQ
What is the specific nature of the 'Other Events' reported by IN8bio, Inc. on June 24, 2025?
The filing does not specify the exact nature of the 'Other Events'; it is listed as the item of disclosure.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 24, 2025.
Where are IN8bio, Inc.'s principal executive offices located?
IN8bio, Inc.'s principal executive offices are located at 350 5th Avenue, Suite 5330, New York, New York 10118.
What is the Commission File Number for IN8bio, Inc.?
The Commission File Number for IN8bio, Inc. is 001-39692.
What is the IRS Employer Identification Number for IN8bio, Inc.?
The IRS Employer Identification Number for IN8bio, Inc. is 82-5462585.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding IN8BIO, INC. (INAB).